Meliora Therapeutics

CHARM Therapeutics

This company develops small-molecule drugs for cancer patients using a deep-learning platform that models protein-ligand interactions to identify novel therapeutic targets.

Serinus Biosciences

This company develops an artificial intelligence platform to design cancer therapeutics and combination therapies for the pharmaceutical and precision medicine industries.

Cold Start Therapeutics

This company develops multimeric fusion proteins using machine learning to target cancer cells and engage immune cells for patients with oncological diseases.

Pragma Biosciences

This company develops a drug discovery platform using machine learning to identify microbiome-derived small molecules for pharmaceutical and healthcare partners.

Pragma Bio

This company develops a machine learning platform to discover and manufacture microbiome-derived small molecule medicines for patients with immunological disorders and cancer.

Known Medicine

This company develops a platform using 3D cell culture and artificial intelligence to predict drug responses for oncologists and biopharmaceutical developers.

Harmonic Discovery

The company develops a machine learning platform to design multi-targeted kinase therapeutics for pharmaceutical firms and healthcare providers treating cancer and autoimmune diseases.

Orakl Oncology

This company develops a predictive platform using patient tumor avatars and data to help pharmaceutical firms accelerate and de-risk cancer drug development.